Emplicure AB publishes the Annual Report 2022

2023-05-23 13:31

The 2022 Annual report of Emplicure AB (publ) is now available on the Company's website.

The annual report is available in PDF format on the Company's website at:


Printed copies of the annual report can be ordered from Emplicure AB, Virdings allé 32B, SE-754 50 Uppsala, or by e-mail: info@emplicure.com.

For additional information, please contact

Håkan Engqvist

Phone: +46 702 569 500
Email: hakan.engqvist@emplicure.com

Erik Magnusson

Phone: +46 708 565 245
Email: erik.magnusson@emplicure.com

Certified Adviser

Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank.

The following documents can be retrieved from beQuoted
PM-Emplicure AR2022-ENG-2023-05-23.pdf
Emplicure-AR-2022 ENG.pdf

Emplicure develops new and innovative products by combining existing and approved active substances with advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain and on abuse-deterrent formulations. The subsidiary Amplicon AB develops consumer products with oral nicotine as the first product. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com

Do you want to know more?